Enduring Response to Everolimus as Third-Line Therapy in a Patient With Advanced Renal Cell Carcinoma, Including Small-Bowel Metastases: Loss of FHIT but Normal VHL Gene Status
Autor: | Broom, Reuben J., Caldwell, Imogen, Hanning, Fritha, Fong, Peter, Deva, Sanjeev, Oei, Paul |
---|---|
Zdroj: | In Clinical Genitourinary Cancer September 2012 10(3):202-206 |
Databáze: | ScienceDirect |
Externí odkaz: |